Login / Signup

Impact of Heart Failure History at Baseline on Cardiovascular Effects of GLP-1 Receptor Agonists in Type 2 Diabetes: a Meta-analysis.

Mainak BanerjeeIndira MaisnamSatinath Mukhopadhyay
Published in: Cardiovascular drugs and therapy (2023)
GLP-1RAs consistently prevented HF hospitalizations and MACE in T2DM regardless of baseline HF history, whereas significant attenuation of benefits on composite HHF/CV death were observed in those with HF history.
Keyphrases
  • acute heart failure
  • heart failure
  • type diabetes
  • glycemic control
  • cardiovascular disease
  • left ventricular
  • atrial fibrillation
  • metabolic syndrome
  • wild type